Assignee
ABIVAX
FR·31 granted patents·18 pending applications·78 citations·filing 2013–2025
Top patents by PatentIndex Score
49 records- 0195US10981874B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2019·Granted Apr 20, 2021·5 cites·22 claims
- 0294US10683284B2Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2018·Granted Jun 16, 2020·7 cites·10 claims
- 0394US10253020B2Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature agingABIVAX·Filed 2017·Granted Apr 9, 2019·8 cites·13 claims
- 0493US9637475B2Compounds for treating cancerABIVAX·Filed 2015·Granted May 2, 2017·13 cites·27 claims
- 0592US10017498B2Compounds useful for treating AIDSABIVAX·Filed 2015·Granted Jul 10, 2018·9 cites·18 claims
- 0690US10435370B2Quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2015·Granted Oct 8, 2019·11 cites·22 claims
- 0788US10718770B2Methods for screening compounds for treating or preventing a viral infection or a virus-related conditionABIVAX·Filed 2016·Granted Jul 21, 2020·4 cites·24 claims
- 0886US11649211B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·1 cites·16 claims
- 0986US9827237B2Compounds useful for treating diseases caused by retrovirusesABIVAX·Filed 2014·Granted Nov 28, 2017·10 cites·12 claims
- 1086US2025100971A1In vitro or ex vivo methods for screening a quinoline derivativeABIVAX·Filed 2024·Application pending·0 cites
- 1186US2026035348A1Phenyl-n-quinoline derivatives for treating a rna virus infectionABIVAX·Filed 2025·Application pending·0 cites
- 1283US9969715B2Compounds useful for treating cancerABIVAX·Filed 2013·Granted May 15, 2018·5 cites·8 claims
- 1382US12479802B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2024·Granted Nov 25, 2025·0 cites·7 claims
- 1480US12202804B2In vitro or ex vivo methods for screening a quinoline derivativeABIVAX·Filed 2022·Granted Jan 21, 2025·0 cites·19 claims
- 1579US12084422B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 10, 2024·1 cites·12 claims
- 1679US10717724B2Compounds useful for treating cancerABIVAX·Filed 2018·Granted Jul 21, 2020·1 cites·15 claims
- 1778US11441181B2miRNA-124 as a biomarkerABIVAX·Filed 2014·Granted Sep 13, 2022·1 cites·14 claims
- 1874US11649210B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·0 cites·17 claims
- 1974US2024343716A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2024·Application pending·0 cites
- 2073US2025275994A1Quinoline Derivatives For Use In The Treatment Of Inflammation DiseasesABIVAX·Filed 2024·Application pending·0 cites
- 2172US10975063B2Compound, and production method thereof, and methods of treatment using the compoundABIVAX·Filed 2019·Granted Apr 13, 2021·0 cites·18 claims
- 2271US2025032474A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2024·Application pending·0 cites
- 2370US11826372B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 2469US11992499B2Quinoline derivatives for use in the treatment of inflammation diseasesABIVAX·Filed 2019·Granted May 28, 2024·0 cites·38 claims
- 2568US10329317B2Quinoline derivative for use in the treatment and prevention of viral infectionsABIVAX·Filed 2016·Granted Jun 25, 2019·1 cites·10 claims
- 2667US11014918B2Compounds and pharmaceutical compositions containing at least one of the compoundsABIVAX·Filed 2020·Granted May 25, 2021·0 cites·10 claims
- 2766US12247018B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 2865US12421206B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 23, 2025·0 cites·17 claims
- 2964US10870671B2Method of preparation of alpha galactosyl ceramides compoundsABIVAX·Filed 2013·Granted Dec 22, 2020·1 cites·12 claims
- 3064US2025170119A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2023·Application pending·0 cites
- 3164US2025099454A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a jak inhibitorABIVAX·Filed 2023·Application pending·0 cites
- 3263US11427566B2Compounds useful for treating cancerABIVAX·Filed 2020·Granted Aug 30, 2022·0 cites·16 claims
- 3363US2022127253A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2021·Application pending·0 cites
- 3461US11739073B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Aug 29, 2023·0 cites·21 claims
- 3558US11266667B2ABX196 for use in the treatment of bladder cancerABIVAX·Filed 2018·Granted Mar 8, 2022·0 cites·8 claims
- 3657US11278552B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2017·Granted Mar 22, 2022·0 cites·10 claims
- 3756US10538485B2Compounds for use as therapeutic agents affecting P53 expression and/or activityABIVAX·Filed 2017·Granted Jan 21, 2020·0 cites·11 claims
- 3856US2022071985A1Quinoline derivatives for use in the treatment or prevention of cancerABIVAX·Filed 2019·Application pending·0 cites
- 3954US2023142547A1Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infectionABIVAX·Filed 2021·Application pending·0 cites
- 4053US2025145651A1Method of preparation of 1-(n-(quinolin-2-yl)-(phenylamino)-1-deoxy-beta-d-glucopyranuronic acid derivativesABIVAX·Filed 2022·Application pending·0 cites
- 4153US2022145406A1Biomarkers, and uses in treatment of viral infections, inflammations, or cancerABIVAX·Filed 2019·Application pending·0 cites
- 4251US2024182422A1Preparation method of quinoline derivative compoundsABIVAX·Filed 2022·Application pending·0 cites
- 4350US2023106420A1Aryl-n-aryl derivatives for treating a rna virus infectionABIVAX·Filed 2020·Application pending·0 cites
- 4449US9556489B2Use of RBM39 as a biomakerABIVAX·Filed 2013·Granted Jan 31, 2017·0 cites·16 claims
- 4541US10806729B2Quinoline derivatives for use in the treatment or prevention of viral infectionABIVAX·Filed 2016·Granted Oct 20, 2020·0 cites·15 claims
- 4641US2023218605A1Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amineABIVAX·Filed 2021·Application pending·0 cites
- 4739US2023067676A1Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amineABIVAX·Filed 2021·Application pending·0 cites
- 4835US2017197938A1A quinoline derivative for the treatment of inflammatory diseases and aidsABIVAX·Filed 2015·Application pending·0 cites
- 4933US2019185548A1Antiviral polyclonal antibodies against ebola virus and the uses thereofABIVAX·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABIVAX files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →